Literature DB >> 25976680

Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology.

Pengli Zheng1, Qiao Wang1, Junlin Teng1, Jianguo Chen2.   

Abstract

Tumor metastasis is a key cause of cancer mortality, and inhibiting migration of cancer cells is one of the major directions of anti-metastatic drug development. Calumenin and fibulin-1 are two extracellular proteins that synergistically inhibit cell migration and tumor metastasis, and could potentially be served as targets for pharmacological research of anti-metastatic drugs. This review briefly introduces the multi-function of these two proteins, and discusses the mechanism of how they regulate cell migration and tumor metastasis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-metastasis; Calumenin; Cell migration; Fibulin-1

Mesh:

Substances:

Year:  2015        PMID: 25976680     DOI: 10.1016/j.phrs.2015.05.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  USP6 activation in nodular fasciitis by promoter-swapping gene fusions.

Authors:  Nimesh R Patel; John S A Chrisinger; Elizabeth G Demicco; Stephen F Sarabia; Jacquelyn Reuther; Erica Kumar; Andre M Oliveira; Steven D Billings; Judith V M G Bovée; Angshumoy Roy; Alexander J Lazar; Dolores H Lopez-Terrada; Wei-Lien Wang
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

2.  Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer.

Authors:  Dubravka Škalamera; Mareike Dahmer-Heath; Alexander J Stevenson; Cletus Pinto; Esha T Shah; Sheena M Daignault; Nur Akmarina B M Said; Melissa Davis; Nikolas K Haass; Elizabeth D Williams; Brett G Hollier; Erik W Thompson; Brian Gabrielli; Thomas J Gonda
Journal:  Oncotarget       Date:  2016-09-20

3.  Quantitative proteomics approach reveals novel biomarkers and pathological mechanism of keloid.

Authors:  Jian Liu; Chunhua Yang; Huayu Zhang; Wei Hu; Jonas Bergquist; Helen Wang; Tingzhi Deng; Xueling Yang; Chao Zhang; Yanping Zhu; Xiaodong Chi; Jia Mi; Yibing Wang
Journal:  Proteomics Clin Appl       Date:  2022-04-26       Impact factor: 3.603

4.  Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.

Authors:  Jason P Webber; Lisa K Spary; Malcolm D Mason; Zsuzsanna Tabi; Ian A Brewis; Aled Clayton
Journal:  Oncotarget       Date:  2016-04-12

5.  MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression.

Authors:  Akiko Kunita; Shigeki Morita; Tomoko U Irisa; Akiteru Goto; Toshiro Niki; Daiya Takai; Jun Nakajima; Masashi Fukayama
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

6.  Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma.

Authors:  Ying Yang; Jin Wang; Shihai Xu; Fei Shi; Aijun Shan
Journal:  Transl Neurosci       Date:  2021-02-03       Impact factor: 1.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.